(SPNT) Siriuspoint - Overview
Stock: Reinsurance, Insurance, Aviation, Marine, Property
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 29.3% |
| Relative Tail Risk | -6.05% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.18 |
| Alpha | 35.72 |
| Character TTM | |
|---|---|
| Beta | 0.560 |
| Beta Downside | 0.521 |
| Drawdowns 3y | |
|---|---|
| Max DD | 16.28% |
| CAGR/Max DD | 2.60 |
Description: SPNT Siriuspoint January 14, 2026
SiriusPoint Ltd. (NYSE: SPNT) is a Bermuda-based insurer and reinsurer that delivers multi-line products worldwide through two operating segments: Reinsurance and Insurance & Services.
The Reinsurance segment underwrites aviation and space, accident & health, casualty, credit, marine & energy, and property risks for other insurers, governments and specialty vehicles, while also offering medical insurance, trip-cancellation, and 24/7 emergency assistance services. The Insurance & Services segment writes accident & health, marine & energy, property & casualty, mortgage, environmental, workers’ compensation, commercial auto, professional liability, and other commercial lines.
In 2023 the company reported net written premiums of roughly $2.0 billion, a combined ratio of 95% in its core reinsurance book, and a capital adequacy ratio exceeding 150%, reflecting strong solvency. SiriusPoint’s earnings are increasingly sensitive to the global reinsurance pricing cycle and to macro-economic factors such as interest-rate trends that affect investment income, as well as the rising frequency of climate-related catastrophes that drive demand for capacity.
For a deeper quantitative view of SiriusPoint’s valuation metrics, the ValueRay platform provides a concise dashboard of its financial ratios and peer comparisons.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: 198.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA 0.46 > 1.0 |
| NWC/Revenue: 225.3% < 20% (prev 126.6%; Δ 98.73% < -1%) |
| CFO/TA 0.02 > 3% & CFO 232.1m > Net Income 198.3m |
| Net Debt (100.1m) to EBITDA (339.8m): 0.29 < 3 |
| Current Ratio: 4.56 > 1.5 & < 3 |
| Outstanding Shares: last quarter (118.8m) vs 12m ago -31.24% < -2% |
| Gross Margin: 27.42% > 18% (prev 0.29%; Δ 2713 % > 0.5%) |
| Asset Turnover: 22.59% > 50% (prev 20.61%; Δ 1.98% > 0%) |
| Interest Coverage Ratio: 4.11 > 6 (EBITDA TTM 339.8m / Interest Expense TTM 79.8m) |
Altman Z'' 3.91
| A: 0.51 (Total Current Assets 8.20b - Total Current Liabilities 1.80b) / Total Assets 12.46b |
| B: 0.08 (Retained Earnings 988.5m / Total Assets 12.46b) |
| C: 0.03 (EBIT TTM 328.3m / Avg Total Assets 12.57b) |
| D: 0.10 (Book Value of Equity 1.05b / Total Liabilities 10.25b) |
| Altman-Z'' Score: 3.91 = AA |
What is the price of SPNT shares?
Over the past week, the price has changed by -0.44%, over one month by -4.52%, over three months by +5.51% and over the past year by +42.19%.
Is SPNT a buy, sell or hold?
- StrongBuy: 0
- Buy: 0
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the SPNT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 25 | 22% |
| Analysts Target Price | 25 | 22% |
| ValueRay Target Price | 27.3 | 33.3% |
SPNT Fundamental Data Overview February 01, 2026
P/E Forward = 8.4317
P/S = 0.8339
P/B = 1.1961
Revenue TTM = 2.84b USD
EBIT TTM = 328.3m USD
EBITDA TTM = 339.8m USD
Long Term Debt = 682.5m USD (from longTermDebt, last quarter)
Short Term Debt = 1.40m USD (from shortTermDebt, last quarter)
Debt = 682.5m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 100.1m USD (from netDebt column, last quarter)
Enterprise Value = -49.5m USD (2.38b + Debt 682.5m - CCE 3.12b)
Interest Coverage Ratio = 4.11 (Ebit TTM 328.3m / Interest Expense TTM 79.8m)
EV/FCF = -0.21x (Enterprise Value -49.5m / FCF TTM 232.1m)
FCF Yield = -468.8% (FCF TTM 232.1m / Enterprise Value -49.5m)
FCF Margin = 8.17% (FCF TTM 232.1m / Revenue TTM 2.84b)
Net Margin = 6.98% (Net Income TTM 198.3m / Revenue TTM 2.84b)
Gross Margin = 27.42% ((Revenue TTM 2.84b - Cost of Revenue TTM 2.06b) / Revenue TTM)
Gross Margin QoQ = 31.96% (prev 29.80%)
Tobins Q-Ratio = -0.00 (set to none) (Enterprise Value -49.5m / Total Assets 12.46b)
Interest Expense / Debt = 3.08% (Interest Expense 21.0m / Debt 682.5m)
Taxrate = 18.21% (20.2m / 110.9m)
NOPAT = 268.5m (EBIT 328.3m * (1 - 18.21%))
Current Ratio = 4.56 (Total Current Assets 8.20b / Total Current Liabilities 1.80b)
Debt / Equity = 0.31 (Debt 682.5m / totalStockholderEquity, last quarter 2.21b)
Debt / EBITDA = 0.29 (Net Debt 100.1m / EBITDA 339.8m)
Debt / FCF = 0.43 (Net Debt 100.1m / FCF TTM 232.1m)
Total Stockholder Equity = 2.07b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.58% (Net Income 198.3m / Total Assets 12.46b)
RoE = 9.58% (Net Income TTM 198.3m / Total Stockholder Equity 2.07b)
RoCE = 11.93% (EBIT 328.3m / Capital Employed (Equity 2.07b + L.T.Debt 682.5m))
RoIC = 10.59% (NOPAT 268.5m / Invested Capital 2.54b)
WACC = 6.76% (E(2.38b)/V(3.07b) * Re(7.98%) + D(682.5m)/V(3.07b) * Rd(3.08%) * (1-Tc(0.18)))
Discount Rate = 7.98% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -17.27%
[DCF Debug] Terminal Value 85.40% ; FCFF base≈210.5m ; Y1≈259.6m ; Y5≈442.1m
Fair Price DCF = 84.23 (EV 9.94b - Net Debt 100.1m = Equity 9.84b / Shares 116.8m; r=6.76% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 57.60 | EPS CAGR: 144.9% | SUE: -2.12 | # QB: 0
Revenue Correlation: 69.12 | Revenue CAGR: 13.87% | SUE: 0.71 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.67 | Chg30d=-0.015 | Revisions Net=+1 | Analysts=2
EPS next Year (2026-12-31): EPS=2.42 | Chg30d=-0.020 | Revisions Net=+1 | Growth EPS=+0.4% | Growth Revenue=+5.9%